Research on antecedent configuration of knowledge advantages for innovative performance of pharmaceutical manufacturing industry under technology-organization-environment frameworkZHU Wang-wang, TAO Qun-shan, TAO Shi-qi, FU Rui961-970
Construction of the benefit distribution mechanism about pharmaceutical industrial technology innovation strategic alliance based on bargaining gameHUA Dong, WANG Yan-hui971-977
Exploration and inspiration of orphan drug registration systems at home and abroadFANG Zhong-jian, LIN Le-ting, WANG Cai-yi, SHEN Chen, ZHANG Liang, WANG Ying-xia, ZHU Si-qi, SHAO Rong, SHAO Ming-li, FAN Yu-lu978-983
An introduction to the determination path and management model of chemical initial products in JapanLIU Yi-lin, NING Li-li, LI Fang, AN Na, HA Li-li, GUO Zhi-xin984-987
Current situation and prospect of immunoglobulin A as therapeutic drugsSHI Jiang-long, SUN Wen-ze, PAN Yong-bing988-995
Research progress in the chemical composition,pharmacological effects,and quality control of Omphalia LapidescensYANG Yang, WANG Jue, YANG Hui-ying, YANG Rui, XIAO Xin-yue1002-1008
Matrix effects in liquid chromatography-mass spectrometry analysis techniquesFENG Yuan-yuan, TIAN Ye, YIN Li-hui, NING Bao-ming1009-1020
The role and regulation mechanism of macrophage polarization in liver fibrosis and the intervention of traditional Chinese medicinePENG Wang-xia, LU Hua-guan, XIE Xin, LIU Jian-jun1021-1031
Optimization of the formulation of IMP-RH60/mPEG-PLLA micelles by central composite design-response surface methodology and its evaluation in vitroLI Qiu-xiang, DONG Wei, ZHOU Ai-xian, ZHAO Guo-wei, LU Yong-feng, SHI Shang, LIANG Xin-li1032-1042